Provider Backlash Threatens to Gut MU Public Health Objectives

The chorus of health care provider complaints about growing federal HIT requirements, from Meaningful Use (MU) to switching to ICD-10 diagnosis codes threatens to claim some public health victims.  On February 19 the Meaningful Use workgroup of the US HIT Policy Committee (HITPC) responded to the latter’s pressure to reduce the number of Stage 3 MU objectives by voting to delete electronic reporting of reportable lab results (ELR), syndromic surveillance (SS), and reducing requirements for reporting to public health registries.  They declined to endorse a new objective for clinical case reporting of reportable conditions, but appear posed to recommend continuing reporting to immunization information systems (IIS, often called immunization registries) and adding the capability for EHRs to upload immunization histories from an IIS.

Ironically, ELR and SS were common (but far from universal) even before Meaningful Use. An impediment to rapid expansion of ELR to new hospitals was the need to convert in-house lab codes to LOINC (but this is now MU-required for in-hospital lab reporting anyway).  Meanwhile, providers that had happily submitted HL7 Admission, Discharge and Transfer (ADT) messages for SS in the past were confronted by more complex message requirements in Meaningful Use rules.  Some providers questioned why they should spend time and money sending standardized data when many public health jurisdictions could not accept it electronically.   Thus these efforts resemble half-built bridges, with those on neither shore willing to invest enough to finally meet in the middle.

The MU Workgroup decisions reflect a narrowing of HITPC focus from simultaneously meeting five large social goals (one being improving public and population health) to enabling “transformation of care” as envisioned in medical homes and accountable care organizations.

Some providers might enjoy short-term savings by avoiding MU standardized reporting, but then face ongoing costs and retarded outbreak response associated with inefficient manual reporting.  Of course such cost-efficacy depends on health department adoption of standardized electronic reporting.  Progress was reported in 2013 with 95% of jurisdictions receiving some ELR, and the share of 20 million annual reports received electronically rising 62% from 54% in 2012. That represents 1,600,000 fewer manual reports yearly and 1,600,000 more communicable illnesses addressed more quickly and efficiently, just in the earliest stages of MU.

Public health advocates are typically best represented at the MU workgroup level, so greater effort is required to modify HITPC recommendations and proposed rules changes. The MU Workgroup will return to the discussion (unclear how final are the recommendations at this point) on  March 4 and it seems likely HITPC will take up the topic March 11.  Interested parties can tune in.  Health.e.volution has learned the Joint Public Health Informatics Task Force of public health associations is crafting a strategy, so concerned agencies and individuals can contact their association to get involved.

Stage 2 MU Guidance for Health Departments Published, Funding Lags

The first year of Stage 2 Meaningful Use requirements is coming up fast (October, 2013).  Meaningful use participants will need to achieve ongoing submission of public health reports to health departments.  A multi-organizational taskforce has issued guidance materials for local and state health departments to help them 1) declare their readiness to receive data from eligible professionals (EPs) and hospitals (EHs); 2) establish systems whereby EPs and EHs register their intent to submit data; 3) on-board data submitters; and 4) provide necessary acknowledgement of on-going data submission.  That’s a lot to get ready for!  (Some health departments are also acquiring electronic health record (EHR) systems and will themselves need to demonstrate that they are meeting other Meaningful Use objectives as well.)

Unfortunately, as in earlier years, the President’s FY 2014 proposed budget fails to include dedicated funding to help health departments exchange information with EHR systems (with the notable exception of the National Healthcare Safety Network, which is not part of Stage 2 Meaningful Use regulations).  State health departments are heavily dependent (45%) on federal funding, especially from the Centers for Disease Control and Prevention (CDC).  While several CDC funding programs encourage recipients to use funds for achieving connectivity for Meaningful Use Population and Public Health objectives, CDC’s proposed budgets for programs that would support meaningful use objectives (like immunization and emergency preparedness) would shrink in 2014.  Health departments may indirectly benefit from increased funding for ONC if it facilitates health information exchange, and in a few states partial funding for public health information exchange is addressed in state Medicaid plans.  Most affected health departments will need to make do with existing or shrinking resources as Stage 2 ratchets up expectations.

The ONC’s budget proposal (page 33) seems to suggest that ONC is establishing a dashboard of public health participation in meaningful use information exchange.  This would be an important indicator for policy-makers and public health advocates to watch.

Meaningful Use and the Learning Health System-HIMSS

At the 2013 Health Information Management Systems Society (HIMSS) meeting in New Orleans on March 3 I’ll provide guidance to the Physician IT Seminar on how to convert Meaningful Use advances in electronic health records and health information exchange into real learning opportunities to improve care and health.  The Institute of Medicine’s vision for a Learning Health System is “by 2020, 90% of clinical decisions will be supported by accurate, timely, and up-to-date clinical information and will reflect the best available evidence.”  How do the Meaningful Use rules carry us closer to this goal?

I’ve diagrammed critical elements for a learning health system, below.  At its base, and most critically, the electronic health record (EHR) captures information.  This may be entered by clinicians, or received from either patients or other health care providers.  This use of the EHR to “learn about the patient” is fundamental to all other improvements in care.

Various objectives in Stage 1 and 2 Meaningful Use require data capture.  They also require that EHRs be able to exchange information with other clinicians and to some extent with patients.  Meaningful Use objectives also require public health reporting, quality reporting, and decision support, each setting the stage for still more sophisticated learning.

Today, naturally, many providers are obsessed with the implementation of the Meaningful Use objectives and the receipt of incentive payments.  But it is never too soon to consider how these EHR objectives can be pressed into the service of “accurate, timely, and up-to-date clinical information and… the best available evidence.” It is already happening.   For example, in late 2012 a mysterious surge in fungal meningitis cases was detected in Tennessee, and was rapidly traced to certain lots of injection steroids produced by the New England Compounding Center.  Little was known about how to treat the predominant fungus,  Exserohilum rostratum.  Investigators used electronic health record reviews to rapidly identify exposed patients, and to track the success of treatment.   A rapid decline in case mortality among infected persons resulted within just two weeks.  That is truly a learning health system in action.*

Information alone does not bring about learning.  Learning requires a “central nervous system” to process incoming information in light of other knowledge.   Public health agencies, like local and state health departments, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) are examples of such “central nervous systems.”  But a good brain is useless without being attached to sensory and motor organs.   The Exserohilum rostratum outbreak helps show the Meaningful-Use-certified EHR is beginning to serve a valuable sensory function.   Equipped with decision support tools, it is destined to be a powerful motor organ as well.

 

*Thanks to the American Medical Informatics Association Public Health Informatics Workgroup for a great webcast on informatics use and needs associated with this outbreak.

Stage 2 Meaningful Use begins this year. Is public health ready?

Thousands of eligible professionals and hospitals will have to meet Stage 2 requirements for the Electronic Health Record (EHR) Incentive Program (“Meaningful Use”) in the coming year.  Some hospitals may seek to attest to Stage 2 objectives as soon as 12 months from now.  For healthcare providers, failure to achieve objectives can put thousands or millions of dollars of incentive payments at risk.  Will health departments be ready to meet them half way in information exchange?  The answer depends on whether they are preparing now.  Absent a strong project plan in the next few months, the answer may be “no”.

Here is a checklist for health departments to consider:

1. Are you prepared for MORE DATA?  The standard for Stage 2 rises to on-going data submission, rather than just sending a test message.   Are you ready to receive, parse and use steady streams of data from many healthcare providers?  Health departments can still manage the pace of on-boarding new providers, but must do so in a way that does not put providers at risk (see points 6 and 7).

2. Are you ready to accept MORE TYPES of reporting from each provider?  In Stage 1 providers could select only one of several “menu” public health objectives.  Some menu options in Stage 1 are now required (“core”) in Stage 2.  For example, hospitals must submit ALL OF immunization data,  electronic laboratory reporting and syndromic surveillance reports to health departments ready to accept them.   Eligible professionals must submit immunization data AND  select from other menu objectives (including several public health options) to obtain their incentive.

3. Are you prepared to use HL7v2.5.1 messages for immunizations and syndromic surveillance?  Two standards to choose from in Stage 1 created confusion and frustration, so there is only one standard for each Stage 2 objective.   However…

4. Are you willing to GRANDFATHER providers that have achieved on-going submission of HL7v2.3.1 messages in Stage 1?  This option is up to the health department, and can help you avoid having to re-on-board those providers already successfully submitting data using HL7v2.3.1.  Any new data providers must use v2.5.1 however.

5. Will you accept CANCER REGISTRY data documents using the Clinical Document Architecture standard specified in Stage 2? Do you intend to sponsor any other SPECIALIZED REGISTRIES in 2014?   These are new “menu” options for Eligible Professionals.

6. Do you have a plan to publicly DECLARE READINESS of what public health reporting objectives you will offer for Eligible Professionals and Eligible Hospitals during each reporting period?  Because providers need timely and definitive information, Stage 2 rules now allow providers to claim EXEMPTION from public health meaningful use objectives if such a declaration is not publicly available for their jurisdiction.  (Public health departments need not receive data for any or all objectives, but if they wish providers to be motivated by Meaningful Use incentives to submit data, they must publicly state in advance of each reporting period which objectives will be accepted.)  A closely related issue: if more than one jurisdiction in a state receives Meaningful Use data submission (for example, if there are both local and state level syndromic surveillance or immunization information systems) are state and local departments planning to COMMUNICATE CLEARLY  which exchange opportunities and requirements apply to which jurisdictions?

7. How will you manage Eligible Professionals and Eligible Hospitals that intend to initiate data submission during each reporting period?  Stage 2 rules require providers to REGISTER their intent to submit data with the appropriate health department.   The health department need not then immediately on-board the provider, but has the option to later disqualify a registered provider from receiving incentives if it fails to respond within 30 days to two written requests to take action (i.e., to begin sending test data, or to adjust transmission, structure or vocabulary to the required standards).

8. Do you intend to DESIGNATE a Health Information Exchange to receive some public health data submissions?  To ensure good end-to-end transmission of reports, HIEs cannot claim to substitute for health departments unless they are designated to do so.

9. Is there CLOSE COORDINATION and a RESPONSIBLE OVERALL MANAGER linking planning with each of the affected surveillance programs (and jurisdictions), the state HIT coordinator, Medicaid director and HIT Extension Center?

[And 10. for health departments using EHRs and enrolled in the EHR Incentive Program: Will my EHR migrate to 2014 edition certification standards, and can we meet Stage 2 objectives to earn our incentive?]

Obviously, serious planning is needed.  Some health departments may be asking: is all this worth the effort?  It is critical to remember that:

1. Meaningful use is establishing the de facto standards that will be used for information exchange in the future.  The faster health departments adopt the new national standards and on-board data submitters, the faster they can be automating data management and the detection and management of critical events.   This can serve both effectiveness AND efficiency.  National data and exchange standards will foster the ability of vendors and development of systems to aid health departments with these tasks.

2. Before long, most providers will have electronic health records that are all certified to capture and transmit information in standardized ways.   Onerous reporting processes for providers, and incomplete reporting to health departments, can both be addressed to the benefit of both through automation.  

3. Health departments can decide the pace at which they enroll providers in Meaningful-Use-specified data exchange.  Health department participation is optional, but Meaningful Use incentives (and later, penalties) will induce providers to begin submission whenever the health department is ready.   What the new Stage 2 rules demand in return is that health departments communicate clear plans and requirements to providers.  It is the latter who then face financial loss if objectives aren’t met.

4. The new rules continue to support the idea of “queuing providers” and on-boarding them at the pace the health department can tolerate.  Once providers are registered, they are not at risk of losing their incentive UNLESS they fail to respond timely (30 days) to requests from the health department.  The health department can invite registered providers to initiate data exchange at whatever pace is practical, and neither party “gets hurt.”

5. Stage 3 will likely move beyond surveillance to improving preventive care delivery.  For example, immunization information systems (which by Stage 3 will be bulging with information submitted by hundreds of thousands of healthcare providers) will likely be able to alert professions to immunizations patients lack, using the EHR during the context of care.

It may be a tough slog now, but there’s much to gain at the far end!

Fortunately, a Stage 2 Task Force of affected public health associations has formed under the leadership of the Joint Public Health Informatics Task Force, the Centers for Disease Control and Prevention (CDC), and the Office of the National Coordinator for Health Information Technology (ONC).  It will soon be issuing fact sheets and other tools, which will likely be distributed at the NACCHO ePublic Health Blog among other modalities.

 

 

Dear NPR: There IS a treatment for that diagnosis: electronic health records and immunizations

NPR’s All Things Considered yesterday described “growing pains” in health information technology (HIT) by saying many doctors in Colorado had to enter immunization records twice: first into their Electronic Health Record (EHR) system, and then into the state’s immunization registry.   According to the story, many doctors fail to do both

In fact, immunization registries, the Centers for Disease Control and Prevention, the HHS Office of the National Coordinator for HIT, and the Centers for Medicare and Medicaid Services (CMS) have worked together to implement solutions for this problem.*  The federal EHR Incentive Program (better known as “Meaningful Use”) includes an objective for EHR systems to upload shot records into immunization registries, eliminating the “double entry” problem.  The Colorado registry has implemented the necessary standards, and instructions for doing so are published on the same website cited in the NPR story.

This process is still not simple.  But the needed standardization is further improved in Stage 2 of Meaningful Use, scheduled to begin in October 2013.  And in October 2015 federally-certified EHRs could be required to download immunization records and alerts for clinicians about which vaccines a patient lacks.   Such automated data and reminders are needed to accelerate the completeness of childhood immunization which remains subpar.

I appreciate NPR’s attention to this challenging issue.  But while various difficulties affect the transition to electronic health records, NPR inadvertently selected a success story to illustrate the problems.

*Full disclosure: I was among those involved in this collaboration.

 

Meaningful Use Stage 3: An Urgent Checklist for Public Health

The clock is running for public health advocates to advise what should be included in Stage 3 of the Electronic Health Records (EHR) Incentive Program (“Meaningful Use” (MUse)).

January 14, 2013 is the deadline for comment on the Health IT Policy Committee’s recommendations for Stage 3.

  • A key issue is whether EHRs should be certified in Stage 3 to generate electronic public health reports using a new, standardized approach.   The Public Health Reporting Initiative is finalizing both a harmonized data element profile and a Clinical Document Architecture implementation guide in the next few weeks.*   These are based largely on the Cancer Registry reporting standard that appears in Stage 2 MUse rules and on implementations already in place for the National Healthcare Safety Network (NHSN) and recommended for Stage 3.  Adopting the PHRI approach need not require change to existing MUse reporting activities like electronic laboratory reporting, immunization registries or syndromic surveillance.  However, it provides a reusable, modular, and extensible methodology that could be leveraged by these and many other types of reporting (for example, communicable disease case reports, product safety reports, birth and death reports) into the future.
  • The public health (and health IT) communities should examine the PHRI documents to decide if they represent an achievable step toward more generic interoperability between EHR and public health surveillance systems.  If so, they will have to make their voices heard during the comment period, because MUse Stage 3 certification is NOT recommended by the HIT Policy Committee (rather, it is recommended for some future, unspecified time).
  • The Centers for Disease Control and Prevention (CDC), which funds much US public health surveillance, needs to decide and announce whether it will support pilot implementations, full-scale implementation, and health department migration to the new approach going forward.
  • The Office of the National Coordinator and CDC need to ensure that PHRI products  are harmonized with similar initiatives across the ONC Standards and Interoperability Framework, and curated and maintained over time.
  • Other important issues in the Stage 3 recommendations include EHR data capture of information like occupation and disability; whether NHSN hospital reporting should be included as a new objective; and whether additional public health registries should be offered as choices in the incentive program.
Unfortunately, these decisions are being made at a time of significant vacancies and uncertainty in the decision-making structure at CDC.   Representatives of local and state health departments, who are critical stakeholders in this process, will need to study, act and advise CDC, rather than depend on the agency.  But the CDC Meaningful Use program is sponsoring a half-day Virtual Conference on public health and Meaningful Use Tuesday, December 18 beginning at 12ET.   This should provide a good orientation to Stage 2 changes, and set a foundation for discussion of Stage 3.
Meanwhile, the urgent deadlines of MUse and ONC (sometimes labelled the “Office of No Christmas” for its December demands) loom.  Inaction over the holidays might lead to a lump of coal in the public health stocking for Stage 3.**
—————-
* Disclosure: Author was a lead team member of the of the Public Health Reporting Initiative from October 2011-September 2012.
** References to Christmas are for humorous purposes only and do not imply an endorsement of any particular holiday or religion.  Happy holidays to all, whichever you celebrate.

Meaningful Use Stage 3 and Beyond: What’s in there (with one surprise) for public health?

While healthcare providers and public health departments continue to study how Stage 2 of the Electronic Health Record (EHR) Incentive Program, or “Meaningful Use,” will affect them beginning October 2013, the Health Information Technology Policy Committee has issued a Request for Comment (RFC) on proposals for Stage 3 and beyond that may shape the program after October 2015.  Comments are due January 14, 2013.  At least some of these proposals, shaped by comment, will re-appear in a Notice of Proposed Rule Making (and yet another round of public comment) next year.

The RFC unexpectedly pushed back a proposal for electronic case reporting of reportable conditions to an indefinite time AFTER Stage 3 (see below).  Because the two Population and Public Health objectives targeted “after Stage 3” have been to focus of rapid and intensive work in the Public Health Reporting Initiative, they will likely merit further discussion as to timing.

Some items of public health interest for Stage 3 (by my own arbitrary criteria–you should read the RFC!) include:

  • Adding the capability to record occupation & industry codes, sexual orientation and gender identity (optional fields) and disability status to EHR certification requirements (while not setting goals for provider capture of these elements)
  • Using vital signs and lab results to support up-to-date problem lists (e.g., to use vital signs to signal potential hypertension on the problem list)
  • RETIRING requirements to capture blood pressure, BMI and smoking status because recording is already at high levels (<80%, data source unstated).  Progress will be tracked through hypertension and tobacco use quality measures instead.
  • Increasing clinical decision support interventions from 5 to 15, including preventive services and chronic disease management, especially hypertension control and dosing of drugs for renal impairments.
  • Change recording family history to recording high priority (unspecified) family history
  • Educational materials made available in at least one non-English language based on which of the top-five non-English languages in US are spoken locally
  • Transitions-of-care now specifically include referrals.  Care summaries should include the identity of care team members like care coordinators, and EHR certification includes the ability to populate a referral form for specific referrals including smoking quit-lines.
  • Notifying care coordinators (when appropriate) of significant healthcare events like emergency department visits or hospital admission or discharge.
  • EHR  importation and use of structured historical immunization data from immunization information systems (registries), and to receive, generate or access age-, gender-, and immunization-history-based immunization recommendations.  The EHR certification criteria would requires the EHR to use standard rule sets and patient data to recommend immunization.
  • Continuation without change to electronic laboratory reporting and syndromic surveillance reporting.
  • Adding other mandated jurisdictional registries beyond cancer registries for which Eligible Professionals (and now Hospitals) may perform successful ongoing data submission to achieve a menu (optional) objective.  In other words, cancer registries could be replaced by other registries in the menu objective for Eligible Professionals (and Eligible Hospitals would be offered a menu option for registry reporting for the first time).
  • Adding a second menu option for standardized reporting to a second registry, which could include those from professional societies, public health jurisdictions or other aggregators (e.g. Accountable Care Organizations).  It is a new requirement that such reporting use a national standard (“e.g., consolidated CDA”).
  • Sending healthcare associated infection reports to the National Healthcare Safety Network (at least 10% of all reports sent from the certified EHR)

Two items of interest are pegged for “future stages” (i.e., after Stage 3).  While it seems likely that HHS will continue to add future objectives and repairs to the program, the timing and nature of such activity is currently undefined.

  • EHRs should determine when a case report of a reportable condition need be sent to a public health agency, and should send at least 10% of initial case reports electronically.   [“Case report” means clinical information on a case for which a laboratory report of a reportable condition may or may not have been sent separately.  NOTE that in earlier discussions by the HIT Policy Committee this objective was slated for Stage 3.]
  • Reporting of adverse event (related to, e.g., vaccines, devices, EHRs, drugs or biologics) reports to FDA and/or CDC.

Dr. Thomas Frieden, Director of the Centers for Disease Control, can see satisfaction of his request that Stage 3 tackle improved clinical hypertension control, support for tobacco quit line referrals, and bidirectional communication with immunization information systems.  Other voices, inside and outside CDC, have had additional goals, and many of these are reflected as well.   Some of the key questions the public health (and larger Health IT) community must answer:

  • Should at least some form of public health case reporting be pushed forward into Stage 3?   Will the necessary message or document standard be ready in time, AND will a meaningful number of health departments be ready to receive it?  [Look for a post on this topic shortly.]  Is it necessary to have a national public health knowledge system that provides rules for public health reporting, or could jurisdictional requirements be manually programmed into EHRs?  And who will drive to these answers and assure needed tools are created?  [Disclosure: I served as a co-chair of the Public Health Reporting Initiative for a year until September, 2012.]
  • Should cancer registries be demoted to just “one of” a variety of public health disease registries?
  • If a standard format is created to report to disease registries, will public health (and non-public health) registries be able to convert in time?
  • Will state health departments have adapted to receiving and managing CDA documents for Cancer Registries in Stage 2, and can they apply this to other use cases (possibly case reporting or additional disease registries) for Stage 3?
  • And the perennial question: will health departments be drowning in data from Stage 2, or will they successfully harness the many new ongoing data streams into more effective and efficient case management and health surveillance systems?
Answers to these questions must come in large part from health departments themselves.   Many track developments using CDC’s Meaningful Use webpage.   The Joint Public Health Informatics Taskforce of the Association of State and Territorial Health Officials, the National Association of County and City Health Officials, and seven other national public health associations, will doubtless be crafting a consensus response to RFC, and would likely welcome your thoughts as they do so.
Several more posts on Stage 2 and Stage 3 Meaningful Use objectives will follow.

 

Who Leads Informatics at CDC?

Hard on the heels of my own departure from the US Centers for Disease Control and Prevention (CDC) on September 30 comes a clean sweep of high-level informatics leaders in the organization.   Sources now confirm that James Buehler, MD the current Director of the Public Health Surveillance and Informatics Program Office (PHSIPO) will depart before year’s end.  His supervisor, PHS Rear Admiral (ret.) Steven Thacker, a long-time advocate for cross-cutting integration, is also slated to leave his post as Director of the Office for Surveillance, Epidemiology and Laboratory Services (OSELS).  These departures follow at least three years of marked funding reductions at CDC’s informatics core.

[Update 12/11/12: We’ve learned Dr. Buehler is departing for family reasons, and Dr. Thacker for health reasons.  Friends and colleagues of Dr. Thacker can connect with him and his family here.]

Few signals indicate the future direction for informatics at the Agency.   Acting leadership for OSELS will be placed in the hands of Denise Cardo, MD, director of the Division of Healthcare Quality Promotion, and Dan Jernigan MD, MPH of the National Center for Immunization and Respiratory Diseases (NCIRD) as her deputy.  While Buehler and I were recruited from outside CDC, both of the new OSELS leads come from powerful National Centers in CDC’s Office of Infectious Disease.  This may (but also may not) indicate a plan to redistribute the OSELS portfolio across the National Centers (sometimes called “Silos of Excellence”). 

The timing for an apparent leadership vacuum and dwindling resources could not be worse.  It comes in the middle of a massive one-time Federal investment of tens of billions of dollars in healthcare information technology and exchange.  Standardization engendered by the “Meaningful Use” electronic health record incentive program could enable major progress in public health programs if two conditions are met.  First, cash-strapped local and state public health agencies must make it a priority to migrate to new, more uniform standards and must have the resources to do so.   Second, critical public health requirements for information exchange must be successfully negotiated with cost-averse healthcare providers and their information system vendors.  Neither can be accomplished without dedicated leadership and resources.  The need for a confident, skillful, flexible and funded approach to public health information exchange with healthcare providers has never been greater.  We anxiously await the announcement of both new a new informatics vision and stable leadership at CDC.